TY  - JOUR
AB  - By conducting indepth interviews with the CEO and top management of TTY Biopharm Company, a Taiwan-based pharmaceutical company, I depict the role of TTY’s intellectual capital in building competitive advantages and enhancing the achievement of corporate strategies. TTY’s success illustrates that even in a relatively small pharmaceutical market such as Taiwan, where a full-range new drug R&D, covering from discovering new chemicals to developing new drugs, seems economically infeasible, adopting fit R&D strategies and developing intellectual capital to establish competitive advantages can overcome the limitations in home market size and bear fruitful results.
AU  - Chen, Ming-Chin
DA  - 2004
LA  - eng
IS  - Journal of Business Chemistry
M2  - 14
N1  - Section "Research Paper"
PY  - 2004
SP  - 14-20
T2  - Journal of Business Chemistry
TI  - Intellectual capital and competitive advantages: the case of TTY Biopharm Company
UR  - https://nbn-resolving.org/urn:nbn:de:hbz:6-45649598552
Y2  - 2024-11-22T11:18:41
ER  -